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Human stratum corneum was extracted in Tris-HCl 
containing EDT A and phenylmethylsulfonyl fluoride, 
separated on sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis, transblotted to nitrocellulose papers 
and reacted with rabbit antihuman epidermal transglu-
taminase (ETG) antibody. Protein-bound antibody was 
detected with a multistep peroxidase procedure. Pro-
teins with a molecular weight of 50,000 (50kDa) and 
72,000 daltons (72kDa) were stained when anti-ETG 
was used and not when second antibody alone or sera 
from nonimmunized animals were used. When ETG was 
treated with trypsin or organic solvents, there was no 
alteration in the mobility of the 50kDa ETG band, but 
there was complete disappearance of the 72kDa band. 
Antibody that bound 72kDa protein, when eluted from 
the blot reacted with both 50kDa and 72kDa proteins; similar}~, antibody that bound to t~e 50kDa protein, 
when eluted from the blot, reacted With both the 50kDa 
and 72kDa proteins. Partially purified 72kDa ETG ac-
tivity was increased (3 to 16 times control levels) after 
heating at 56°C in the presence of calcium and dithio-
threitol or by treatment with trypsin. 
These studies, in conjunction with the previous studies 
of ETG activation, are consistent with there being two 
forms of ETG. The different forms may play a role in 
regulating enzyme activity. 
The transglutaminases (R-glutaminyl-peptide:- amine- -y -
glutamyl t ransferase, E.C. 2.3.2.13) , a h eterogenous group of 
Ca++ dependent enzymes, catalyze t h e formation of -y-glutamyl-
~-lysine isopeptide bonds which can cross-link proteins. These 
enzymes are biochemically and immuhoch emically distinct 
[1,2], and multiple forms of transglutaminase can exist within 
the same tissue [3]. 
Regulation of epidermal transglutaminase (ETG) determines 
the timing and extent of cell ~n:'~lope formation (reviewed in 
[4]) . Activation [4- 7] or mhlblt!On [4 ] of transglutaminase 
activity may directly affect cell envelope formation in kerati-
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nocytes in tissue culture . Some treatments can increase trans-
glutaminase activity and not increase cornified envelope for-
mation [8]. 
In this paper we describe a new high-molecular-weight form 
of human ETG. 
MATERIALS AND METHODS 
[1,4-"C]Putrescine dihydrochloride (109 mCi/ mmol) was purchased 
from Amersham (Arlington Heights, Illinois) and Aquasol-II from New 
England Nuclear (Boston, Massachusetts). a -Casein, Staphylococcus 
aureus VS protease, and trypsin-TPCK were obtained from Worthing-
ton Biochemical Co. (Freehold, New Jersey) . Phenylmethylsulfonyl 
!luoride (PMSF), plasmin, ethylenediaminetetraacetic acid (EDTA), 
chymotrypsin, 4-chloro-1-naphthol, were from Sigma Chemical Com-
pany, (St. Louis, Missouri). Plasminogen activator (Winkinase, 250,000 
CTA units) was kindly provided by Dr. Gerald Lazarus, Department 
of Dermatology, University of Pennsylvania. Peroxidase-conjugated 
affinity-purified goat antirabbit IgG was purchased from Cappel Lab-
oratories (Cochranville, Pennsyvania). A!l other reagents were of the 
highest grades avai lable. 
Polyclonal rabbit antibody for human ETC was prepared by Ogawa 
and Goldsmith [2]. 
Tran.sglutamin.ase Preparation 
Transglutaminase was prepared from human skin scales obtained 
from a patient with lamellar ichthyosis. Scales were finely minced with 
scissors, homogen ized in 10 vol of 0.25 M sucrose, and centrifuged at 
17,000 g for 15 min at 4•c. The supernatant solution was saved and 
the pellet rehomogenized in neutral buffer containing 0.1 M Tris-HCl, 
pH 8.0, 0.15 M NaCl, wit h or without 1 mM EDTA and O.lmM PMSF, 
and centrifuged as above. Both supernatants were combined and con -
centrated 10-fold by ultrafiltration using an Amicon YM-5 filter at 
4· c . 
Neonatal foreskin epidermis was prepared by heating to 56·c for 30 
sin distilled water and mechanically separating epidermis from dermis. 
The epidermis was extracted in 0.1 M Tris-HCl, pH 8.0, with 0.15 M 
NaCl, 1 mM EDTA, and 0.1 mM PMSF. Foreskin epidermal cells were 
grown in t issue culture and the keratinocytes extracted directly into 
the same buffer, or in some cases extracted as foresk in. 
Protein. Separation. and Immun.operoxidase Staining 
Extracted proteins were separated by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) [9] and gels were either 
stained or transblotted to sheets of nitrocellulose [ 10]. Molecular weight 
standards were bovine serum albumin, egg albumin, carbonic anhy-
drase, and trypsin inhibitor. Gel blots were processed for immunologic 
studies and reacted with rabbit antihuman transglutaminase [2] fol-
lowed by goat antirabbit lgG horseradish peroxidase-conjugated second 
ant ibody. Horseradish peroxidase was developed using 4-chloro-1-
naphthol in 0.01 % H202 [11] . 
Cross-Reactivity of An.ti-50kDa and An.ti-72kDa Tran.sglutamin.ase 
Antibody 
Specific antibodies, anti-50kDa and anti-72kDa transglutaminase 
antibody, were prepared from whole rabbit antitransglutaminase anti-
sera using affinity purification as described by Olmsted [12]. Briefly, 
extracted proteins were separated on SDS-PAGE, transferred to a 
nitrocellulose sheet, and reacted with antitransglutaminase antibody 
at room temperature overnight. After locating transglutaminase by 
irnmunoperoxidase staining on a portion of the blot, the 50kDa, 72kDa, 
and control zones were cut out from the non stained remainder o( the 
blot. These strips were t hen washed with several changes of elution 
buffer (50 mM Tris-HCI, pH 7.5, 5 mM EDTA, 0.15 M NaCl) and placed 
in separate 5-cc syringes. Three milliliters of 0.2 M glycine-HCl, ph 2.8, 
was added to t he syringe and left for 3 min. This solution was forced 
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through the strips twice and then neutralized wi th 1 N NaOH. The 
eluant was diluted to 10 ml with phosphate-buffered saline and concen-
t rated to 0.5 ml by ul t rafil t ration with an Amicon YM-5 filter. Finally, 
t hese affinity-purified antibodies were reacted with 50kDa and 72kDa 
zones on another nitrocellulose blot using a dot-immunobinding assay 
[11]. 
Staphylococcal VB Peptide Mapping of 50kDa and 72kDa 
Transglutaminase 
Peptide maps were performed on 50kDa and 72kDa bands from 
SDS-PAGE as described by Cleveland eta! [13]. Gel slices were exposed 
to 5- 500 ng Staphylococcus aureus VB protease during electrophoresis 
through a 4-cm stacking gel. An additional 30-min incubation without 
current was included just prior to entry of bromphenol blue into 
separating gel. Gels were stained with Coomassie blue following elec-
trophoresis. 
Activation of Transglutaminase 
Extracts in neutral buffer were preincubated in the presence of 0.1 
mg/ml of a variety of proteases at 37•c. At intervals from 0-120 min, 
25 ~tl of the preincubation mixture was removed and assayed for 
transglutaminase activity as previously described [6]. In addition, an-
other 25 ~tl of preincubation mixture was added to an equal volume of 
concentrated (2X) Laemmli [9] sample buffer for SDS-PAGE. Control 
samples were preincubated under the same conditions without added 
enzyme. Similar activation studies were performed with t rypsin, chy-
motrypsin , plasminogen activator, and plasmin. Activation with di thi-
othreito l (DTT) and heating were performed as previously described 
[5]. 
High-Pressure Liquid Chromatography 
High-pressure liquid chromatography, (HPLC), was performed with 
Waters 721 p rogrammable system controller, 730 data module, 510 and 
6000A pumps, and a 441 detector at 280 nm. Proteins were separated 
using Protein Pak DEAE 5PW (10 J.lm) column (7.5 mm x 7.5 em) 
(Waters, Milford, Massachusetts) elu ted at 1 ml/min with a 30 ml 
linear gradient of 0- 0.5 M NaCI in 20 mM Tris-HCI, pH 8.5. One-
mi ll ili ter fractions were collected, al iquots (50 Ill) assayed for transglu-
tam inase activity and/or activation, and the molecular weights of 
proteins in active fractions determined by SDS-PAGE as described. 
RESULTS 
The effect of extraction conditions on the molecular weight 
of transglutaminase is demonstrated in t he immunoblot in Fig 
1. When transglutaminase is extracted from human scales in 
neutral buffer without protease inhibitors, transglutaminase is 
detected as a si ngle 50kDa band by its specific a n t ibody (Fig 
lA, lane 1 ). When 0.1 mM PMSF, a serine protease inhibitor, 
and 1.0 mM EDTA are added to extraction buffer, a second 
positive staining band appears at 72kDa on immunoblots (Fig 
lA, lane 2). T he total activity extracted was twofold higher 
when PMSF a nd EDT A were present. The 72kDa band is a 
doublet or triplet with one to two faint bands seen just below 
the 72kDa band. No staining was seen whe n a rabbit nonim-
mune serum or second a n t ibody a lone was used in t he immu-
noblot. Extracts from cu ltured human kerati nocytes and neo-
natal foreskin epidermis studied under similar conditions had 
predominantly 72kDa bands on immunoblots (Fig lB) . 
In order to determine whether t he 50kDa and 72kDa proteins 
contained a n identical a n t igenic determinen t, t he a n tibody to 
each protein was affini ty purified as shown in Fig 2. Antibody 
that bound to 72kDa protein, when e luted from t he blot, reacted 
with both 50kDa and 72kDa proteins. S imila rly, a n t ibody that 
bound to 50kDa protein, when elu ted from t he b lot, reacted 
with both 50kDa a nd 72kDa proteins. Control study using 
whole antitransglutaminase a n t ibody or combined a nti-72kDa 
and anti-50kDa antibodies a lso was positive on both antigens. 
A band of 30kDa sta ined weakly and broadly espec ia lly in blots 
of heavily loaded samples. Antibody eluted from t he 50kDa a nd 
72kDa proteins reacted wit h that protein band (data not 
shown) . 
Fig 3 shows the peptide maps of 50kDa and 72kDa proteins 
digested with Staphylococcus aureus V8 protease at various 
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FIG 1. lmmunoperoxidase staining of transglutaminase under the 
different extraction conditions. A, Transglutaminases extracted in 
neutral buffer containing 0.1 M Tris-HCl, pH 8.0, 0.15 M NaC l, with 
(Lane 2) or without (lane 1) 1 mM EDTA and 0.1 mM PMSF were 
separated by SDS-PAGE, electrophoretically t ransferred to ni troce l-
lulose, and immunoblots were done using rabbit antihuman t ransglu-
tammase as described in Materials and Methods. Appropriate controls 
for immunoblots, a rabbit non immune serum, or second antibody alone, 
were performed simultaneously. B, Immunoblots of neutral buffer 
extract stratum corneum from lamellar ichthyosis (SC), cul tured ke-
rat inocytes (CK), and neonatal foreskin epidermis (F) prepared as 
described in Materials and Methods and stained with antihuman t rans-
glutaminase. The numbers 72 and 50 indicate apparent molecular 
weights (kDa) derived from molecular weight markers as described in 
Materials and Methods. 
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FIG 2. Cross-reactivi ty of anti-50kDa and anti-72kDa transglutam-
inase antibody. Specific antibodies, anti-50kDa and anti-72kDa trans-
glutaminase antibody were prepared from whole rabbi t antitransglu-
taminase antisera (aTGase) using affinity purificaton as described in 
Materials and Metlwds. These affini ty-purified antibodies (a50kDa 
anti-50kDa; a72kDa, ant i-72kDa; a50kDa and a72kDa, an ti -50kD~ 
and anti-72kDa mixed) were reacted with 50kDa and 72kDa zones 
punched out from another nitrocellulose blot using a dot-immunobind-
ing assay. 
concentrations. Depending on the concentration ofV8 protease, 
t he number of cleavage fragments was increased. Five na no-
grams caused some digestion, while 25 ng resulted in ma ny 
fragments of 50kDa, 42kDa, 40kDa, 33kDa, 3lkDa, a nd 25kDa. 
One hundred twenty-five na nograms and 500 ng produced 
fragments of the same molecular weights as 25 ng, but in 
addit ion, smaller peptides of 23kDa, 22kDa, 19kDa, a nd 15kDa 
were seen. With 500 ng, there was no undigested start ing 
materia l of either 72kDa or 50kDa transglutaminase a nd both 
showed digested peptides prominently at 3lkDa and 25kDa 
with some sma ller fragments. At all V8 protease concentrations, 
t here were at least 5 identical peptides (3 unequivocally repro-
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clueing in photographs) found from digests of 72kDa or 50kDa 
transglutaminase. 
As seen in Fig 4A, preincubation with 0.1 mgj ml of trypsin 
caused a time-dependent enhancement of transglutaminase 
activity, up to 3 times control values after 2-h incubation. The 
effect of trypsin on the 50kDa and 72kDa protein staining of 
irnmunoblots is seen in Fig 4B. At 0 and 15 min both 50kDa 
and 72kDa bands were present and of about equal intensity. 
By 30 min and 45 min the intensity of staining of the 72kDa 
band had progressively diminished with concomitant increase 
in the intensity of staining of the 50kDa band. Immunologic 
staining of the 72kDa band was completely eliminated by 60 
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FIG 3. A, Peptide maps of 50kDa and 72kDa transglutaminase 
digested with Staphylococcus au~eus VB protease. Stratum corneum 
extracts in neutral buffer contammg 1 mM EDTA and 0.1 mM PMSF 
were separated on SDS-PAGE. Gel slices of 50kDa and 72kDa bands 
(as indicated) were applied to a second SDS·PAGE (15% acrylamide) 
in the presence of varying a_mounts (25, 125, 500 ng) of Staphylococcus 
aureus V8 protease as mdicated; electrophoreSIS w_as earned out as 
described in Materials and Methods. Molecular we1ght markers and 
their apparent molecular wei_ghts are in the leftmost gel lane and on 
the left side of the gel respectively. B, D1gestwn patterns of 50kDa and 
72kDa bands wi th 500 ng of Staphylococcus aureus VB protease enlarged 
from the left panel. Peptide fragments with the same molecular weights 
were observed. The numbers 72 and 50 refer to the molecular weight 
of the starting material. 
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min and 50kDa showed maximum intensity of stain, which was 
unchanged at 120 min. At all time points the mobility of 50kDa 
was unaffected. The presence of a third staining band of about 
30kDa is not altered by trypsin. 
The effects of plasmin and plasminogen activator were also 
examined (data not shown). There was no enhancement of 
transglutaminase activity over a range of concentrations of 
plasmin from 0.1-0.5 mg/ml or with incubations up to 2 h in 
duration. Neither was there any alteration in immunologic 
staining of either 50kDa or 72kDa bands. In contrast, 0.1 mg/ 
ml chymotrypsin decreased the activity of transglutaminase 
over control with time. Silver-stained gels and immunoblots of 
enzyme-incubated samples failed to show the presence of either 
50kDa or 72kDa bands (data not shown). 
The neutral buffer extract was chromatographed on DEAE 
columns using HPLC (Fig 5). The 72kDa enzyme reproducibly 
eluted at 0.18 M NaCl as determined by enzyme assays, SDS-
PAGE, and immunoblots. There was a 10-fold increase in 
enzyme specific activity in the fraction containing the 72kDa 
transglutaminase. This fraction was activated by heating in the 
presence of calcium and by trypsin (Table I). After heating 
there was a 16-fold increase of activity. Trypsin (0.1 mg/ml) 
activated 72kDa transglutaminase 2.7-fold above control val-
ues. A 50kDa ETG was not found in HPLC eluates. 
DISCUSSION 
The inclusion of protease inhibitors in our normal extraction 
buffers has allowed us to detect a second form of human ETG. 
The extreme sensitivity of the 72kDa form of ETG to proteo-
lysis prevented detection of this enzyme in our previous studies. 
A serine protease, trypsin, is capable of converting the 72kDa 
form of the enzyme to the 50kDa form. Other proteases, plas-
min , and plasminogen activator had no effect while chymotryp-
sin, under the conditions used, destroyed both forms of the 
enzyme. 
The 72kDa and 50kDa forms of ETG were immunologically 
cross-reactive with affinity-purified antibodies (Fig 2); peptide 
maps confirmed the close biochemical relationship of the ETGs 
(Fig 3). It is possible that conversion between the two forms of 
ETG is responsible for some of the increases in activity during 
normal epidermal differentiation [4], after treatment of mouse 
FIG 4. A, Activation of transglutam-
inase by trypsin. Extracts in neutral 
'-
A Preincubation Time (min.) B 0 15 30 45 60 120 
buffer conta ining 1 mM EDTA a nd 0.1 
mM PMSF (25 1'1) were preincubated in 
a fin al volume of 50 11l at 37"C in the 
presence of 0.1 mg/ ml tryps in. At t he 
indicated t ime in tervals, 25 11l of t he 
preincubation mixture was removed and 
assayed for transglutam inase activity 
(e) as described in MateriaL~ an.d M eth-
ods. Control samples <•l were preincu-
bated under the same conditions without 
added trypsin. B, Immunoblots with an-
titransglutaminase a fter trypsin incuba-
t ion. At the indicated time intervals 
(min.) , after trypsinization, equal vol -
ume of concentrated (2X) Laemmli sam-
ple buffer was added to the t rypsin t rans-
glutaminase reaction mixture and heated 
at lOO"C for 5 min. Twenty microli ters 
of each sample was applied on 80S-
PAGE and electrophoretically trans-
ferred to nitrocellulose. Immunoblots 
were performed using rabbi t antihuman 
transglutaminase as described in Mate-
riaL5 a.nd Methods. 
(min,) 
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FIG 5. DEAE fractionation of human ETG. A, Transglutaminase activity (--• - -); AUFS (absorbance units full scale) (--) ; and NaCl 
molari ty (- - ). ChToma tography as outlined in Materials and Methods. B, Silver stained SDS-polyacrylamide gels of HPLC fractions 
correspondin g to those in panel A. Marker proteins (MP) with appa rent molecula r weight in ki lodaltons as indicated on the left hand side of the 
gel; H PLC fractions as indicated. Highest enzyme activity was in fraction 18 which has a 72kDa protein. C, Immunoblot stained with antihuman 
t ra nsglutaminase. The pa nel a nd fractions correspond to the protein stain in B. 
TABLE I. Effect of lwating and trypsin on 72kDa transglutaminase 
activity 
Fraction with 72kDa ETG 
+ Ca++, DTT, 56"C 
+Trypsin (0.1 mg/ml) 
dpm/50 111 
659 
10,682 
1,770 
% of control 
100 
1621 
269 
HPLC frac t ion contained only 72kDa ETG by immunoblot analysis. 
Activation conditions were as previously described [1,5,6]. 
keratinocytes with tumor promoters [14,15], and retinoid treat-
ment [8,15]. Since transglutaminase from neonatal foreskin 
epidermis and from human epidermal keratinocytes contains 
predominan t ly the 72kDa protein (Fig 1), we do not regard the 
sta te of enzyme to be specifically related to the nature of 
ichthyotic stratum corneum. Thacher and Rice have reported 
multiple forms of transglutaminase in extracts of cultured 
squamous cell carcinoma [16,17] and have suggested different 
roles for the enzyme forms relative to the state of differentiation 
of the cells. The relationship of those transglutaminases to the 
enzymes in this report is unknown. 
It is possible that the two forms of transglutaminase have a 
precursor- product relationship such as exists during activation 
of plasma factor XIII [18,19]. Activation by organic solvents, 
heating, or limited proteolytic digestion was associated with 
the disappearance of protein staining and immunoreactivity of 
the 72kDa tranglutaminase and with increased immunoreactiv-
ity of the 50kDa ETG (Fig 4, and data not shown for organic 
solvent activation) . A fraction containing only 72kDa activity 
could be isolated using HPLC. In this fraction the enzyme 
could be activated by heating to 56"C or with trypsin. Our 
previous studies show comparable enhancement of enzyme 
activity of preparation with almost entirely 50kDa protein after 
similar pretreatments [5,6] . Although the 50kDa and 72kDa 
forms of transglutaminase are immunologically and biochemi-
cally related, the exact nature of the relationship will require 
more detailed studies. 
S. Thacher and R. Rice (Cell 40:685- 695, 1985), have de-
scribed a particulate transglutaminase solubilized with Emul-
gen from culture keratinocytes with a molecu lar weight of 92kD 
by immunoprecipitation. Monoclonal antibodies to that trans-
glutaminase did not immunoprecipitate transglutaminase ac-
tivity in the neutra l buffer extract. The relationship of the 
transglutaminase to the 72kD transglutaminase in this report 
is under study in our laboratory. 
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